Cancer Institute A national cancer institute
designated cancer center
Email this profile
Portrait View Larger

Beverly S. Mitchell, M.D.

Academic Appointments

  • George E. Becker Professor in Medicine and Professor, by courtesy, of Chemical and Systems Biology

Key Documents

Contact Information

  • Clinical Offices
    Stanford Clinical Cancer Center 875 Blake Wilbur Dr Stanford, CA 94305
    Tel Work (650) 725-9621 Fax (650) 736-0607
  • Academic Offices
    Personal Information
    Email Tel (650) 736-7716
    Alternate Contact
    Tonya McPherrin Administrative Associate Tel Work (650) 736-7716
    Not for medical emergencies or patient use

Professional Overview

Clinical Focus

  • Cancer> Hematology
  • Cancer> Hematology> Hematologic Malignancies
  • Cancer> Lymphoma
  • Hematology

Administrative Appointments

  • Director, Stanford Cancer Institute (2008 - present)
  • Deputy Director, Stanford Cancer Center (2005 - 2008)

Honors and Awards

  • Walter Hewlitt Physician Scientist Award, Stanford Department of Medicine (2012)
  • Mentorship Award, American Society of Hematology (2012)
  • President, American Society of Hematology (2001)
  • Member, American Society for Clinical Investigation (to present)
  • Member, Association of American Professors (1991)
  • National Academy of Sciences, Institute of Medicine (Inducted 2001)

Professional Education

Medical Education: Harvard Medical School MA (1969)
Board Certification: Hematology, American Board of Internal Medicine (1978)
Fellowship: University Hospital Zurich, Switzerland (1973)
Fellowship: University of Michigan Hospital MI (1977)
Board Certification: Internal Medicine, American Board of Internal Medicine (1973)
Residency: University of Washington WA (1973)
View All 8



Postdoctoral Advisees

Haruka ItakuraLe Xuan Truong Nguyen

Graduate and Fellowship Program Affiliations

Scientific Focus

Current Research and Scholarly Interests

Beverly S. Mitchell, MD, is the Director of the Stanford Cancer Institute and is the George E. Becker Professor of Medicine at Stanford University. Before joining the Stanford faculty, Dr. Mitchell lead the Molecular Therapeutics Program at UNC Chapel Hill's Lineberger Comprehensive Cancer Center, where she also served as Associate Director for Translational Research and Chief of the Division of Hematology/Oncology.
She has authored over 130 peer-reviewed articles. She served as President of the American Society of Hematology (ASH) and was Chair of the Medical and Scientific Affairs Committee and Vice Chair for Medical and Scientific Affairs of the Leukemia and Lymphoma Society of America.
Dr. Mitchell's current research relates to the development of new therapies for hematologic malignancies. She is interested in preclinical proof of principle studies on mechanisms inducing cell death and on metabolic targets involving nucleic acid biosynthesis in malignant cells. Recent studies have focused on the role of nucleolar proteins in cellular stress responses, including that induced by reactive oxygen species. She is also interested in the regulation of ribosomal RNA synthesis in hematopoietic stem and progenitor cells and in the role of dysregulated synthesis in bone marrow failure syndromes. in addition, her laboratory is involved in the translation of these studies into scientifically designed clinical trials.


Publication tag cloud

Publication Topics

View All 138

Stanford Medicine Resources:

Footer Links: